Clinical trials
Phase 1 Cardiovascular Diseases trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 8 |
| Queen Mary University of London | 3 |
| Bial - Portela C S.A. | 2 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| GlaxoSmithKline | 1 |
| Queen's University, Belfast | 1 |
| ReNeuron Limited | 1 |
| University of Bath | 1 |
| University of Edinburgh | 1 |
| University of Leeds | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 21 |
| Atherosclerosis | 1 |
| COVID-19 | 1 |
| Coronary Artery Disease | 1 |
| Dermatitis | 1 |
| Diabetes Mellitus | 1 |
| Drug-Related Side Effects and Adverse Reactions | 1 |
| Dyslipidemias | 1 |
| Gout | 1 |
| Heart Failure | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.